Herbalife Ltd. (NYSE:HLF) has received a series of recent downgrades, most recently coming from Zacks, which moved the rating to Neutral from Outperform.
While Zacks maintains a price target of $64.20 after the downgrade, over 20% above the current share price near $54, Canaccord Genuity cut their price target from $87 to $73, moving their recommendation form a Buy to a Hold rating.
Barclays raises price target, then Federal Trade Commission announces investigation
The current downgrades come as Barclays PLC (NYSE:BCS) (LON:BARC) had raised their price target on the stock in January to $94 from $78. Two days after Barclays raised...


